Ascari E - Search Results

1

Advanced breast-cancer - a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-Fluorouracil.

Riccardi A, Giordano M, Brugnatelli S, Ucci G, Danova M, Mora O, Fava S, Ascari E. Riccardi A, et al. Among authors: ascari e. Oncol Rep. 1995 Jul;2(4):577-82. doi: 10.3892/or.2.4.577. Oncol Rep. 1995. PMID: 21597779

2

Multicyclic dose-intensive chemotherapy with circulating progenitor cell support for high-risk primary breast cancer.

Danova M, Perotti C, Mora O, Lucotti C, Torretta L, Comolli G, Riccardi A, Salvaneschi L, Ascari E. Danova M, et al. Among authors: ascari e. Oncol Rep. 1998 Mar-Apr;5(2):427-9. doi: 10.3892/or.5.2.427. Oncol Rep. 1998. PMID: 9468573

3

Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes and granulocyte colony-stimulating factor in breast cancer patients.

Danova M, Porta C, Ferrari S, Brugnatelli S, Comolli G, Riccardi A, Ascari E. Danova M, et al. Among authors: ascari e. Oncol Rep. 2000 May-Jun;7(3):585-9. doi: 10.3892/or.7.3.585. Oncol Rep. 2000. PMID: 10767372

4

The use of peripheral-blood hematopoietic progenitors mobilized with standard-dose chemotherapy plus granulocyte-colony-stimulating factor to support multicyclic dose-intensive chemotherapy for advanced breast-cancer.

Danova M, Rosti V, Mora O, Perotti C, Cazzola M, Riccardi A, Ascari E. Danova M, et al. Among authors: ascari e. Oncol Rep. 1995 Nov;2(6):1075-8. doi: 10.3892/or.2.6.1075. Oncol Rep. 1995. PMID: 21597856

5

Cell kinetics of CD34-positive hematopoietic cells following chemotherapy plus colony-stimulating factors in advanced breast cancer.

Danova M, Rosti V, Mazzini G, De Renzis MR, Locatelli F, Cazzola M, Riccardi A, Ascari E. Danova M, et al. Among authors: ascari e. Int J Cancer. 1995 Nov 27;63(5):646-51. doi: 10.1002/ijc.2910630508. Int J Cancer. 1995. PMID: 7591280 Clinical Trial.

6

Myeloprotective effect of early primary granulocyte-colony stimulating factor during six courses of intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer. Cooperative Group of Study and Treatment of Breast Cancer.

Riccardi A, Brugnatelli S, Giordano M, Danova M, Pugliese P, Tinelli C, Klersy C, Richetti A, Fava S, Nastasi G, Rinaldi E, Fregoni V, De Monte A, Trotti G, Bovio A, Ascari E. Riccardi A, et al. Among authors: ascari e. Tumori. 1998 Sep-Oct;84(5):540-6. doi: 10.1177/030089169808400506. Tumori. 1998. PMID: 9862513 Clinical Trial.

7

Circulating progenitor cell release and functional characterization after topotecan plus G-CSF and erythropoietin in small cell lung cancer patients.

Ferrari S, Danova M, Porta C, Comolli G, Brugnatelli S, Pugliese P, Riccardi A, Ascari E. Ferrari S, et al. Among authors: ascari e. Int J Oncol. 1999 Oct;15(4):811-5. doi: 10.3892/ijo.15.4.811. Int J Oncol. 1999. PMID: 10493966

8

Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy in patients with solid tumors.

Danova M, Mazzini G, Alberici R, Lucotti C, Palmeri S, Fincato G, Cazzola M, Riccardi A, Ascari E. Danova M, et al. Among authors: ascari e. Int J Oncol. 1996 Nov;9(5):971-6. doi: 10.3892/ijo.9.5.971. Int J Oncol. 1996. PMID: 21541603

9

A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma.

Riccardi A, Ucci G, Brugnatelli S, Mora O, Merlini G, Piva N, Depaoli A, Barbarano L, Distasi M, Alberio F, Nicoletti G, Morandi S, Rinaldi E, Piccinini L, Ascari E. Riccardi A, et al. Among authors: ascari e. Int J Oncol. 1994 Oct;5(4):833-9. doi: 10.3892/ijo.5.4.833. Int J Oncol. 1994. PMID: 21559649

10

Flow cytometric analysis of multidrug-resistance-associated antigen (P-glycoprotein) and DNA ploidy in human colon cancer.

Danova M, Giordano M, Erba E, Palmeri S, Candiloro V, Riccardi A, Ucci G, Mazzini G, D'Incalci M, Ascari E. Danova M, et al. Among authors: ascari e. J Cancer Res Clin Oncol. 1992;118(8):575-80. doi: 10.1007/BF01211799. J Cancer Res Clin Oncol. 1992. PMID: 1355483

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

369 results

Search Page

Filters